These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7568944)

  • 21. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing.
    Puttaraju M; Been MD
    Nucleic Acids Symp Ser; 1995; (33):49-51. PubMed ID: 8643395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of HIV-1 by a double transdominant fusion gene.
    Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
    Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
    Smith CA; Crotty S; Harada Y; Frankel AD
    Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
    Schwartz S; Felber BK; Pavlakis GN
    J Virol; 1992 Jan; 66(1):150-9. PubMed ID: 1727477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes.
    Willard-Gallo KE; Furtado M; Burny A; Wolinsky SM
    Eur J Immunol; 2001 Apr; 31(4):969-79. PubMed ID: 11298321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
    Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
    Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico mutagenesis of RNA splicing in HIV-1.
    Kim H; Yin J
    Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA binding by the tat and rev proteins of HIV-1.
    Karn J; Dingwall C; Finch JT; Heaphy S; Gait MJ
    Biochimie; 1991 Jan; 73(1):9-16. PubMed ID: 1903308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular approaches to inhibit HIV-1 tat expression and functions.
    Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG
    Year Immunol; 1993; 7():199-204. PubMed ID: 8396820
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular biology of HIV-1: positive and negative regulatory elements important for virus expression.
    Felber BK; Pavlakis GN
    AIDS; 1993; 7 Suppl 1():S51-62. PubMed ID: 8363803
    [No Abstract]   [Full Text] [Related]  

  • 32. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.
    Dis Markers; 1990; 8(1):39. PubMed ID: 2178857
    [No Abstract]   [Full Text] [Related]  

  • 33. Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins.
    Pritchard CE; Grasby JA; Hamy F; Zacharek AM; Singh M; Karn J; Gait MJ
    Nucleic Acids Res; 1994 Jul; 22(13):2592-600. PubMed ID: 8041622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rev-dependent expression of three species of HIV-1 mRNAs (review).
    Fukumori T; Kagawa S; Iida S; Oshima Y; Akari H; Koyama AH; Adachi A
    Int J Mol Med; 1999 Mar; 3(3):297-302. PubMed ID: 10028055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV regulatory proteins: potential targets for therapeutic intervention.
    Rosen CA
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):175-81. PubMed ID: 1540405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
    Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
    J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminoglycoside antibiotics, neamine and its derivatives as potent inhibitors for the RNA-protein interactions derived from HIV-1 activators.
    Hamasaki K; Ueno A
    Bioorg Med Chem Lett; 2001 Feb; 11(4):591-4. PubMed ID: 11229778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragments of the HIV-Tat protein specifically bind TAR RNA.
    Dis Markers; 1991; 9(1):58-9. PubMed ID: 1742953
    [No Abstract]   [Full Text] [Related]  

  • 39. Splicing affects presentation of RNA dimerization signals in HIV-2 in vitro.
    Lanchy JM; Szafran QN; Lodmell JS
    Nucleic Acids Res; 2004; 32(15):4585-95. PubMed ID: 15333691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel mono- and di-DNA-enzymes targeted to cleave TAT or TAT-REV RNA inhibit HIV-1 gene expression.
    Unwalla H; Banerjea AC
    Antiviral Res; 2001 Aug; 51(2):127-39. PubMed ID: 11431037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.